Olivier Brandicourt is a French businessperson who has been at the helm of 6 different companies. Presently, he holds the position of Chairman for Sanofi Biotechnology SAS. Dr. Brandicourt is also on the board of Alnylam Pharmaceuticals, Inc., National Committee on United States-China Relations, Inc. and Dewpoint Therapeutics, Inc. and Vice President & Member at European Federation of Pharmaceutical Industries & Assns and Council Member at International Federation of Pharmaceutical Manufacturers.
In his past career Dr. Brandicourt held the position of Chief Executive Officer & Director at Sanofi, President & General Manager-Emerging Markets at Pfizer Inc. Managing Director at Pfizer Ltd. Managing Director at Pfizer Manufacturing Ireland Unlimited Co. Vice President at Warner-Lambert Co. and Vice President & General Manager at Parke, Davis & Co. LLC (which are all subsidiaries of Pfizer Inc.), Executive Council Member at Bayer AG and Chairman-Management Board at Bayer HealthCare AG (a subsidiary of Bayer AG) and Chairman at Pharmaceutical Research & Manufacturers of America.
Dr. Brandicourt received a doctorate and a graduate degree from Université Paris XII and an undergraduate degree from the University of Paris V.